Related Experiment Videos
Leukocyte-endothelium adhesion molecules in atherosclerosis
1Center for Blood Research and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
The Journal of Laboratory and Clinical Medicine
|November 21, 1998
Summary
Genetic mouse models reveal that leukocyte-endothelium adhesion receptors drive monocyte recruitment in atherosclerosis. Future studies should investigate inhibiting these receptors to combat lesion growth.
Area of Science:
- Cardiovascular research
- Immunology
- Genetics
Background:
- Genetic manipulation of mice offers insights into molecular mechanisms of atherosclerosis.
- Leukocyte-endothelium adhesion receptors are implicated in monocyte recruitment and lesion progression.
Purpose of the Study:
- To evaluate the potential of inhibiting adhesion receptors as an anti-atherosclerotic strategy.
- To determine if blocking adhesion receptors mimics the protective effects observed in deficient mice.
Main Methods:
- Utilizing genetically modified mouse models of atherosclerosis.
- Analyzing the role of leukocyte-endothelium adhesion receptors in monocyte recruitment.
- Comparing lesion development in wild-type versus genetically altered mice.
Main Results:
- Adhesion receptors significantly contribute to monocyte recruitment and atherosclerotic lesion growth.
- Genetic deficiency of these receptors is associated with reduced lesion development.
Conclusions:
- Leukocyte-endothelium adhesion receptors are key targets for therapeutic intervention in atherosclerosis.
- Inhibiting these receptors warrants further investigation for anti-atherosclerotic effects.